Lucy Wall

Western General Hospital — United Kingdom

Medicine · Health Sciences

26h-index8.1kcitations95works0.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroendocrine Tumor Research Advances(34), Lung Cancer Research Studies(25), Neuroblastoma Research and Treatments(22), Cancer survivorship and care(16), Pancreatic and Hepatic Oncology Research(15)

Publications93 total

Correction: Relative telomere length and senescence-associated inflammatory cytokines as blood-based prognostic markers in patients with advanced or resectable gastro-oesophageal adenocarcinoma
British Journal of Cancer·2025Open Access
Relative telomere length and senescence-associated inflammatory cytokines as blood-based prognostic markers in patients with advanced or resectable gastro-oesophageal adenocarcinoma
British Journal of Cancer·2025Open Access
Is there a role for post-operative functional imaging in small intestinal neuroendocrine tumours resected with curative intent?
Endocrine Abstracts·2024
INTRAOPERATIVE ANAPHYLAXIS TO RABBIT ANTI-THYMOCYTE GLOBULIN
Annals of Allergy Asthma & Immunology·2024· 2 cited
Fibroblast activation in cardio-oncology
European Heart Journal·2024
The clinical utility of plasma cell-free DNA (cfDNA) in NET-02: Randomised, phase II trial of liposomal irinotecan (nal-IRI)/5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line (2L) therapy in patients (pts) with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma (PD-EP-NEC).
Journal of Clinical Oncology·2024
Taking a therapeutic and biopsychosocial approach to the neuropsychological interview for assessment of brain tumor survivors
Elsevier eBooks·2024
Adrenocortical carcinoma: selective internal radiation therapy and liver metastases
Endocrine Oncology·2024· 1 citedOpen Access
17 Comparing Cognitive Patient-Reported Outcomes with Neuropsychological Impairment in Patients with Diffuse Glioma.
Journal of the International Neuropsychological Society·2023· 1 citedOpen Access
QOL-17. SLEEP QUALITY DIMENSIONS IN LOW AND HIGH-GRADE GLIOMA SURVIVORS
Neuro-Oncology·2023· 1 citedOpen Access
2157P A phase II randomised controlled trial comparing the cardiotoxicity of capecitabine and S-1
Annals of Oncology·2023Open Access
NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma
EClinicalMedicine·2023· 18 citedOpen Access
Neoadjuvant tyrosine kinase inhibitor therapy in locally advanced differentiated thyroid cancer: a single centre case series
The Journal of Laryngology & Otology·2023· 12 cited
Neoadjuvant tyrosine kinase inhibitor therapy in locally advanced differentiated thyroid cancer: a single-centre case series
European Journal of Surgical Oncology·2023· 2 cited
NET-02 final results: A randomised, phase II trial of liposomal irinotecan (nal-IRI)/5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line (2L) therapy in patients (pts) with progressive poorly differentiated extrapulmonary neuroendocrine carcinoma (PD-EP-NEC).
Journal of Clinical Oncology·2023· 1 cited
SIRT: adrenocortical carcinoma and liver metastases
Endocrine Abstracts·2022
Dabrafenib and Trametinib Therapy for Advanced Anaplastic Thyroid Cancer – Real-World Outcomes From UK Centres
Clinical Oncology·2022· 32 cited
QOL-12. “I’M JUST LIKE A BASKET FULL OF PROBLEMS”: QUALITATIVE STUDY OF COGNITIVE DYSFUNCTION AND QUALITY OF LIFE IN GLIOMA SURVIVORS
Neuro-Oncology·2022· 1 citedOpen Access
Health-related quality of life (HRQoL) in patients (pts) with progressive, poorly differentiated, extra-pulmonary neuroendocrine carcinoma (PD-EP-NEC) enrolled in NET-02: A phase II trial of liposomal irinotecan (nal-IRI)/5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line therapy.
Journal of Clinical Oncology·2022
Untitled
UCL Discovery (University College London)·2022· 159 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Marianne Pavel(10), Jarosław B. Ćwikła(10), Alexandria T. Phan(10), Eva Sedláčková(10), Guillaume Cadiot(10), Guido Rindi(10), Philippe Ruszniewski(10), Michael Sharpe(10), Martyn Caplin(9), Jonathan Wadsley(9), Jane Walker(9), Edward M. Wolin(8), Jaume Capdevila(8), Juan W. Valle(8), Markus Raderer(7), Daniel H. Palmer(7), Gordon Murray(7), Alison Langley(6), John Primrose(6), Paul J. Ross(6)